Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

  • There is currently no data for AFN

Directorate Change

8 Aug 2022 07:00

RNS Number : 1711V
ADVFN PLC
08 August 2022
 

8 August 2022

For immediate release

ADVFN PLC

("ADVFN" or the "Company")

Directorate Changes

 

The Board of ADVFN announces that, after 22 years of service with the Company, Michael Hodges is stepping down from his position as a director and Chairman with immediate effect. Michael Hodges will also resign from his group directorships other than in respect of the Company's wholly-owned subsidiary, All IPO Plc, until a suitable replacement has been identified. 

Thomas Spiller has stepped down from his position as non-executive director of the Company, also with immediate effect. 

The Board thanks Michael and Tom for their services and wishes them both well for the future.

Lord Gold, a non-executive director of the Company, will become the non-executive Chairman of the Company.

In addition to the Board changes, the Company has today cancelled all share options currently held by directors (including those held by Michael Hodges) amounting to 1,251,473 options.

 

Enquiries:

 

For further information please contact:

ADVFN PLC

Jonathan Mullins

+44 (0) 203 8794 460

 

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Michael Cornish 

+44 (0) 207 628 3396

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. The person who arranged for the release of this announcement on behalf of the Company was Jon Mullins, Director.

 

A copy of this announcement will be available on the Group's website: 

 www.advfnplc.com

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGGRGNMGZZZ
Date   Source Headline
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company
4th Apr 202212:25 pmRNSNotice of GM
28th Mar 20228:04 amRNSCorporate Update
22nd Mar 20227:00 amRNSWinners of Financial Awards 2022 Announced
17th Mar 20223:32 pmRNSHolding(s) in Company
17th Mar 20223:32 pmRNSHolding(s) in Company
16th Mar 202210:29 amRNSHolding(s) in Company
9th Mar 20227:00 amRNSCorporate Update
3rd Mar 20225:20 pmRNSCorporate Update
25th Feb 20222:02 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBoard change
23rd Feb 20227:00 amRNSCorporate Update
21st Feb 20227:00 amRNSHalf-year Report
14th Feb 20229:21 amRNSRequisition of general meeting update
8th Feb 202210:54 amRNSStrategic review and end of formal sales process
3rd Feb 202210:47 amRNSForm 8.3 - ADVFN PLC
26th Jan 20221:15 pmRNSRequisition of General Meeting
26th Jan 20227:00 amRNSBest Global Private Investor Multi-Market Informat
24th Jan 20229:35 amRNSForm 8.3 - ADVFN plc
21st Jan 20223:14 pmRNSForm 8.3 - ADVFN plc
19th Jan 20225:03 pmRNSForm 8.3 - ADVFN plc
19th Jan 20224:53 pmRNSForm 8.3 - ADVFN PLC
18th Jan 20227:00 amRNSForm 8 (OPD) ADVFN plc
13th Jan 20227:00 amRNSStrategic review and formal sales process
29th Dec 20215:19 pmRNSHolding(s) in Company
29th Dec 20215:15 pmRNSHolding(s) in Company
23rd Dec 20213:28 pmRNSResult of AGM
22nd Nov 20211:08 pmRNSHolding(s) in Company - Replacement
22nd Nov 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.